(Reuters) - U.S. health regulators on Monday approved an Eli Lilly and Co drug to treat advanced stomach cancer and a form of cancer in the area where the esophagus joins the stomach. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/Kf9MF_Au5zY/story01.htm
Read More
No comments:
Post a Comment